Shenzhen Bioeasy Biotechnology Co., Ltd.

Shenzhen Stock Exchange 300942.SZ

Shenzhen Bioeasy Biotechnology Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2023: -21.78%

Shenzhen Bioeasy Biotechnology Co., Ltd. Return on Equity (ROE) is -21.78% for the year ending December 31, 2023, a -353.30% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2022 was 8.60%, a -65.65% change year over year.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2021 was 25.03%, a 110.02% change year over year.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2020 was 11.92%, a -31.77% change year over year.
  • Shenzhen Bioeasy Biotechnology Co., Ltd. Return on Equity (ROE) for the year ending December 31, 2019 was 17.47%, a -47.38% change year over year.
Key data
Date Return on Equity (ROE) Return on Capital Employed (ROCE) Interest Coverage Ratio Debt to Equity Ratio
Market news
SV Wall Street
Shenzhen Stock Exchange: 300942.SZ

Shenzhen Bioeasy Biotechnology Co., Ltd.

CEO Mr. Zhaoli Xiao
IPO Date Feb. 9, 2021
Location China
Headquarters Room 101, Yirui Biological Building
Employees 389
Sector Consumers Staples
Industries
Cleaning Supplies Baby & Childcare Biotechnology Consumer Packaged Goods Dairy & Milk Frozen Foods Personal Care Pharmaceuticals
Description

Shenzhen Bioeasy Biotechnology Co., Ltd. develops and sells rapid testing instruments and reagents in China. The company offers detection equipment for use in the fields of food, agricultural, dairy, meat, aquatic, honey, drug, and public safety, as well as clinical diagnosis. Shenzhen Bioeasy Biotechnology Co., Ltd. was founded in 2007 and is based in Shenzhen, China.

StockViz Staff

February 2, 2025

Any question? Send us an email